Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 33,151 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Placebo Clear all

Conditions: Severe Asthma
Interventions: Verekitug, Placebo; Drug
Lead sponsor: Upstream Bio Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 28
States / cities: Bakersfield, California • Northridge, California • Upland, California + 21 more

Conditions: Type 2 Diabetes Mellitus
Interventions: LCQ908A, Placebo, Sitagliptin, metformin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 693 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 48
States / cities: Mesa, Arizona • Little Rock, Arkansas • Buena Park, California + 39 more

Conditions: Chronic Pancreatitis
Interventions: Tanezumab, Placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 9
States / cities: Naples, Florida • Wellington, Florida • Tupelo, Mississippi + 3 more

Conditions: Amyloidosis
Interventions: Patisiran; Drug
Lead sponsor: Alnylam Pharmaceuticals; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 14
States / cities: La Mesa, California • Aurora, Colorado • Jacksonville, Florida + 10 more

Conditions: Leiomyoma, Uterine Fibroids
Interventions: Letrozole, Placebo; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Schizophrenia
Interventions: AZD3480; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 66
States / cities: Little Rock, Arkansas • Anaheim, California • Cerritos, California + 63 more

Conditions: Healthy
Interventions: MEDI-560, Placebo; Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 1 Month to 11 Months
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 23
States / cities: Bentonville, Arkansas • Little Rock, Arkansas • Madera, California + 20 more

Conditions: Pre-Diabetic
Interventions: Calcitriol capsules, Oral Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 20 Years to 45 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pain
Interventions: Hydrocodone/Acetaminophen Extended Release, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 4
States / cities: Owing Mills, Maryland • Austin, Texas • San Marcos, Texas + 1 more

Conditions: Subcutaneous Fat
Interventions: CBL-514 Injection, 0.9% Sodium Chloride; Drug
Lead sponsor: Caliway Biopharmaceuticals Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 11
States / cities: Encinitas, California • Aventura, Florida • Alpharetta, Georgia + 8 more

Conditions: Epilepsy, Partial
Interventions: Levetiracetam, Placebo; Drug · Other
Lead sponsor: UCB Pharma; Industry
Eligibility: 1 Month to 4 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 42
States / cities: Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 39 more

Conditions: Pyelonephritis Acute
Interventions: Cephalexin, Cephalexin or placebo; Drug
Lead sponsor: Brett A Faine; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Sylmar, California • Iowa City, Iowa

Conditions: Oral Mucositis
Interventions: IZN-6N4; Drug
Lead sponsor: Izun Pharma Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 4
States / cities: Gainesville, Florida • Miami, Florida • New York, New York

Conditions: Autism Spectrum Disorder, ASD, Autism, PDD
Interventions: Cord Blood Infusion, Placebo; Biological
Lead sponsor: Joanne Kurtzberg, MD; Other
Eligibility: 2 Years to 7 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Early Stage Parkinson's Disease
Interventions: Aplindore, Placebo; Drug
Lead sponsor: Ligand Pharmaceuticals; Industry
Eligibility: 30 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Exercise-induced Joint Pain, Exercise-induced Joint Stiffness, Exercise-induced Joint Cartilage Turnover
Interventions: NEM® brand eggshell membrane, Placebo; Dietary Supplement
Lead sponsor: ESM Technologies, LLC; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Delirium
Interventions: donepezil, Placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 70 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Constipation
Interventions: Senna+ docusate, placebo; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Pulmonary Embolism
Interventions: TS23, Placebo; Drug
Lead sponsor: Translational Sciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 13
States / cities: Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 9 more

Conditions: SARS-CoV Infection, Covid19
Interventions: Nitazoxanide, Placebo Nitazoxanide, Ribavirin, Placebo Ribavirin, Hydroxychloroquine, Placebo Hydroxychloroquine; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Cervical Dystonia
Interventions: ABP-450, Placebo; Drug
Lead sponsor: AEON Biopharma, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 21
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Fountain Valley, California + 17 more

Conditions: Pain, Bone Neoplasm, Neoplasm Metastasis
Interventions: ibandronate [Bondronat], zoledronic acid; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 26
States / cities: Birmingham, Alabama • Sedona, Arizona • Ocoee, Florida + 22 more

Conditions: Chronic Hepatitis C
Interventions: Silymarin, Placebo; Drug · Other
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 5
States / cities: Boston, Massachusetts • Chapel Hill, North Carolina • Philadelphia, Pennsylvania + 1 more

Conditions: Dystonia
Interventions: incobotulinumtoxin A, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 80 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: New York, New York

Search by objective public record fields.

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)

Pilot of Letrozole for Uterine Myomas

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer

Cord Blood Infusion for Children With Autism Spectrum Disorder

The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period

The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand